Saluda Medical Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Net Income	-149.3	-97.83	-92.16
Depreciation & Amortization	2.61	2.63	2.31
Other Amortization	20.61	-	-
Loss (Gain) From Sale of Assets	0.03	0.06	0.07
Loss (Gain) From Sale of Investments	7.15	-	-
Stock-Based Compensation	14.03	3.74	6.26
Provision & Write-off of Bad Debts	0.17	0.37	0.56
Other Operating Activities	1.58	4.37	4.89
Change in Accounts Receivable	-1.68	-5.74	-3.94
Change in Inventory	-17.58	-6.65	-9.15
Change in Accounts Payable	4.33	6.68	7.4
Change in Unearned Revenue	0.55	-	-
Change in Income Taxes	0.35	-0.13	0.43
Change in Other Net Operating Assets	-1.08	-0.83	-2.31
Operating Cash Flow	-118.24	-93.32	-85.66
Capital Expenditures	-1.27	-1.08	-2.37
Investing Cash Flow	-1.27	-1.08	-2.37
Long-Term Debt Issued	172.83	-	-
Long-Term Debt Repaid	-71.45	-	-
Net Debt Issued (Repaid)	101.38	-	-
Issuance of Common Stock	0.09	0.03	0.12
Other Financing Activities	-3.54	-0.31	-
Financing Cash Flow	97.94	-0.28	143.83
Foreign Exchange Rate Adjustments	4.28	-0.26	-0.69
Net Cash Flow	-17.29	-94.95	55.11
Free Cash Flow	-119.51	-94.4	-88.03
Free Cash Flow Margin	-169.87%	-182.66%	-395.93%
Free Cash Flow Per Share	-0.71	-0.56	-0.53
Cash Interest Paid	26.45	-	-
Cash Income Tax Paid	0.1	0.86	0.19
Levered Free Cash Flow	-67.53	-71.68	-
Unlevered Free Cash Flow	-71.12	-68.56	-
Change in Working Capital	-15.11	-6.66	-7.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.